Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma.
about
Tetramerization of human guanylate-binding protein 1 is mediated by coiled-coil formation of the C-terminal α-helicesPathophysiological role of guanylate-binding proteins in gastrointestinal diseasesGuanylate binding protein-1 mediates EGFRvIII and promotes glioblastoma growth in vivo but not in vitro.Generation of mice deficient in both KLF3/BKLF and KLF8 reveals a genetic interaction and a role for these factors in embryonic globin gene silencingProfiling and metaanalysis of epidermal keratinocytes responses to epidermal growth factor.Glioblastoma multiforme - an overview.Emerging insights into the molecular and cellular basis of glioblastoma.Construction and analysis of lncRNA-lncRNA synergistic networks to reveal clinically relevant lncRNAs in cancer.Molecular characterization of EGFR and EGFRvIII signaling networks in human glioblastoma tumor xenografts.HOXB7 promotes invasion and predicts survival in pancreatic adenocarcinoma.Suppression of microRNA-9 by mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity.Epidermal growth factor receptor as a therapeutic target in glioblastoma.Systematic review of protein biomarkers of invasive behavior in glioblastoma.Guanylate-Binding Protein-1 protects ovarian cancer cell lines but not breast cancer cell lines from killing by paclitaxel.Neuronal pentraxin 2 supports clear cell renal cell carcinoma by activating the AMPA-selective glutamate receptor-4Human T cell leukemia virus type I tax-induced IκB-ζ modulates tax-dependent and tax-independent gene expression in T cells.GBP-1 acts as a tumor suppressor in colorectal cancer cells.Guanylate-binding protein 1 (GBP1) contributes to the immunity of human mesenchymal stromal cells against Toxoplasma gondii.Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer.T lymphocytes facilitate brain metastasis of breast cancer by inducing Guanylate-Binding Protein 1 expression.The versatile nature of miR-9/9* in human cancer.
P2860
Q24323235-50D4302B-4975-4CA2-BE5D-F1CEF8125600Q28078361-E90AA304-FE4E-4E3D-82D7-E97EA6246B13Q30277399-F87E51D4-3994-4BEB-BECD-952B7E16AE78Q34347327-0D0E9EA8-BA27-474A-9BDD-B1CFBE9BDBA7Q34580355-97221672-1907-4C2E-B24D-E7269AC7CA33Q34589068-D11A1A4E-C5ED-41B4-83A5-00AD178E7DFBQ35914897-26A6358C-D4C2-493A-A8EE-78E29987A245Q36413098-749C3257-FC1F-4D04-869B-F0C7958D5050Q36455750-05A20D2A-1AAC-40B9-BD5D-CAF29CAF6980Q37401868-F75215C0-6866-47BF-9475-44363EDF9F73Q37626436-4FBD7B0B-890D-4ADD-AD01-5AE24CF7784DQ38098098-7DB9A44F-63A0-4625-AB55-730A109A4C31Q38165795-E4D516E2-3E8A-432D-BAFD-AFCBD55BC20EQ38748476-1E4D35D8-00E6-4E48-9FD3-8FACA8421365Q38981597-F6CB0110-1E8A-4EF7-935D-5CCC258295BAQ39096838-9F94856B-4B7A-4736-934C-A8C6941DE548Q39264514-A9911F80-8410-479D-A5DB-F0B00536670DQ40358072-42A373ED-E0AE-438F-B8A8-789C0FEDC445Q47121717-A1909B5D-50A3-4827-8E97-2F056456D964Q47852200-48E275F0-A4FF-4707-9C3A-B400625244FBQ55174811-1E4F78F2-49BD-4081-9694-1118A86E46C8
P2860
Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma.
@ast
Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma.
@en
type
label
Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma.
@ast
Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma.
@en
prefLabel
Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma.
@ast
Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma.
@en
P2093
P2860
P356
P1476
Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma.
@en
P2093
Akitake Mukasa
Jianhua Zhang
Maria del-Mar Inda
Webster Cavenee
P2860
P304
P356
10.1084/JEM.20111102
P407
P577
2011-12-12T00:00:00Z